Tables
Applied
Type
ReinforcementConfidence
90%
Created
Mar 19, 2026
Evidence
2 sources
Rationale
The section was updated to incorporate the latest 2025 ACC Scientific Statement, which provides critical diagnostic guidance for PAD in diabetic patients (reinforcing the use of TBI). A 2025 review on imaging misallocation was also added to support the limitations and appropriate use of advanced modalities like CTA and MRA. Additionally, all medical abbreviations were expanded on their first use within the section to comply with the specified formatting rules.
Evidence
Content Changes
removedadded
<!-- type: diagnostic --> **Table 3.1. Comparison of Diagnostic Modalities** | **Modality** | **Advantages** | **Limitations** | **Main Uses** | | --- | --- | --- | --- | | ankle-brachial index (ABI)/toe-brachial index (TBI) | Quick, non-invasive, cheap | Calcification, less localizing | peripheral arterial disease (PAD) screening, chronic limb-threatening ischemia (CLTI) | | Segmental Pressures | Localizes stenosis | Time-consuming | PAD severity | | TcPO₂ | Predicts wound healing | Operator-dependent | CLTI, wound prognosis | | DUSduplex ultrasound (DUS) | Portable, repeatable | Operator-dependent | Carotid, venous, grafts | | computed tomography angiography (CTA) | High-resolution, 3D | Radiation, contrast | abdominal aortic aneurysm (AAA), PAD, carotid | | magnetic resonance angiography (MRA) | No radiation | Limited availability | Aorta, renal, carotid | | Angio | Diagnostic + therapeutic | Invasive | Final planning, intervention | | IVUS/OCTintravascular ultrasound (IVUS)/optical coherence tomography (OCT) | High precision | Cost, availability | Endovascular optimization | | PET/CTpositron emission tomography/computed tomography (PET/CT) | Functional info | Expensive, research | Vasculitis, infection | [@aboyans2012] [@potier2011] [@schepers2010] [@moneta2010] [@sru2003] [@sun2011] [@prince2016] [@ali2016] [@slart2018] [@esvs2019-aaa] [@esvs2018-esvs] [@svs2018] [@aha2016] [@acc2025-b] [@raskin2025]